Filgrastim

Get a Price/Quote

Product Details:

Formulations Type Chemical Drug
Formulations Form Liquid
Gender/Age Group Adult
Click to view more
Share Your Product:

Ask A Question Send Inquiry

Product Specifications

Formulations Form Liquid
Gender/Age Group Adult
Formulations Type Chemical Drug

Trade Information

Payment Terms Cash Against Delivery (CAD), Cash on Delivery (COD), Cash Advance (CA), Cash in Advance (CID), Cheque, Delivery Point (DP), Western Union
Sample Available Yes
Sample Policy Sample costs shipping and taxes has to be paid by the buyer
Main Export Market(s) Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
Main Domestic Market All India

Product Description

Filgrastim

ReliGrast is human recombinant Granulocyte Colony Stimulating Factor (G-CSF), which is a specific growth factor known to stimulate production of neutrophils, a type of white blood cells in the body that are essential for fighting infections. It is active during the normal course of hematopoiesis and the hematopoietic stem cells get differentiated into white blood cells in the presence of G-CSF.

G-CSF is a protein having 175 amino acids, and has no glycosylation. E.coli is used for commercial manufacturing of recombinant G-CSF as a biosimilar. ReliGrastÂ® can be therapeutically used for reversing neutropenic conditions due to various reasons. It can be used in chemotherapy induced neutropenia, AIDS-associated neutropenia, congenital, cyclic idiopathic neutropenia. In the clinical trials conducted, ReliGrastÂ® has demonstrated efficacy in reducing the duration of Neutropenia (compared to 9 days) and recovery after ANC Nadir. The reduction in the incidence of Febrile Neutropenia, Grade 4 Neutropenia and Infection is also significant.

ReliGrast is available in the strength of 300 mcg/0.5 ml, as a pre-filled syringe.